Denalitx and Biogen have registered the Phase 2b, randomized, double-blind, placebo-controlled (LUMA) study to determine the efficacy & safety of BIIB122 (LRRK2 inhibitor; DNL151) in 640 participants with #Parkinsons
Phase 2b study to determine the efficacy ... - Cure Parkinson's
Phase 2b study to determine the efficacy & safety of BIIB122 (LRRK2 inhibitor; DNL151) in 640 participants with Parkinsons
2 Replies
•
Key Inclusion criteria:.
.
.
. Screening genetic test results verifying the absence of a pathogenic leucine-rich repeat kinase 2 (LRRK2) variant.
it would be helpful if the clinical trials were done in more locations
Not what you're looking for?
You may also like...
Oral BIIB122/DNL151 Safely Lowers LRRK2 Activity in Phase 1 Trials
Treatment with investigational oral therapy BIIB122/DNL151 safely lowered the activity of disease...
Phase 3, the Lighthouse study, Biogen and Denali, LRRK2 inhibitor BIIB122; New clinical trial registered
New clinical trial registered: Biogen and Denaliti have initiated the 2nd late-stage study of...
Phase 4 study to evaluate efficacy of orally administrated Trehalose in individuals with idiopathic & LRRK2-associated Parkinsons
New clinical trial registered:
NeuromedIRCCS researchers have registered a small (N=20) open...
AnnovisBio has initiated a 6-month Phase 3 study to evaluate 2 different doses Buntanetap (posiphen) in 450 participants with PD
AnnovisBio has initiated a 6-month, placebo-controlled, double-blind Phase 2 study to evaluate...
Encouraging results from the phase-I trial! The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in PD
Highlights
• Oral NR increases brain NAD levels in individuals with Parkinson’s disease
• NR...
Related Posts
Results of a Phase 1b trial of MODAG's oligomer modulator anle138b evaluating the safety tolerability in healthy volunteers
Study finds overabundance of opportunistic pathogens in the guts of persons with Parkinson's- Annovis Bio have published the results of their dose-finding, biomarker study of buntanetap in 14 early Alzheimers & 14 Parkinsons patients
Possible improvement of speech in Parkinsons patients with the encouragement and implementation of a daily walking routine. 
it's unsettling to hear Linda Ronstadt was diagnosed with Parkinsons. An image of her flashes into your mind. Dancing to the beat of a...
